| Sr. No. |
Particular |
Link |
| 1 |
Details of Business |
https://www.samratpharmachem.com/wp-content/uploads/2022/01/Samrat-Company-Profile-2021.pdf |
| 2 |
Terms and conditions of appointment of independent directors |
https://www.samratpharmachem.com/policy/appointment-of-independent-director/ |
| 3 |
Composition of various committees of board of directors |
https://www.samratpharmachem.com/board-committees/ |
| 4 |
Code of conduct of board of directors and senior management personnel |
https://www.samratpharmachem.com/code-of-conduct/ |
| 5 |
Details of establishment of vigil mechanism/ Whistle Blower policy |
https://www.samratpharmachem.com/policy/whistleblower/ |
| 6 |
Criteria of making payments to non-executive directors, if the same has not been disclosed in annual report |
https://www.samratpharmachem.com/policy/remuneration-policy/ |
| 7 |
Policy on dealing with related party transactions |
https://www.samratpharmachem.com/policy/related-party-transactions-its-materiality/ |
| 8 |
Policy for determining ‘material’ subsidiaries |
https://www.samratpharmachem.com/policy/material-subsidiary-and-its-governance/ |
| 9 |
Details of familiarization programmes imparted to independent directors |
https://www.samratpharmachem.com/policy/familiarization-program-for-independent-directors/ |
| 10 |
The email address for grievance redressal and other relevant details |
https://www.samratpharmachem.com/share-transfer-agent/ |
| 11 |
Contact information of the designated officials of the listed entity who are responsible for assisting and handling investor grievances |
https://www.samratpharmachem.com/share-transfer-agent/ |
| 12 |
Financial information including:
|
| 13 |
Shareholding Pattern |
https://www.samratpharmachem.com/share-holding-pattern/ |
| 14 |
Schedule of analysts or institutional investors meet and presentations made by the listed entity to analysts or institutional investors. Explanation: For the purpose of this clause ‘meet’ shall mean group meetings or group conference calls conducted physically or through digital means |
– |
| 15 |
Audio or video recordings and transcripts of post earnings/quarterly calls, by whatever name called, conducted physically or through digital means, simultaneously with submission to the recognized stock exchange(s), in the following manner:
(i) The presentation and the audio/video recordings shall be promptly made available on the website and in any case, before the next trading day or within twenty-four hours from the conclusion of such calls, whichever is earlier
(ii) The transcripts of such calls shall be made available on the website within five working days of the conclusion of such calls |
– |
| 16 |
Items published in the Newspaper:
|
| 17 |
Items in sub-regulation (1) of regulation 47 (The listed entity shall publish the following information in the newspaper) (financial results,notices given to shareholders by advertisement) |
https://www.samratpharmachem.com/statutory-communications/ |
| 18 |
All credit ratings obtained by the entity for all its outstanding instruments, updated immediately as and when there is any revision in any of the ratings |
https://www.samratpharmachem.com/achievements/ |
| 19 |
Separate audited financial statements of each subsidiary of the listed entity in respect of a relevant financial year, uploaded at least 21 days prior to the date of the annual general meeting which has been called to inter alia consider accounts of that financial year |
– |
| 20 |
Secretarial Compliance Report |
https://www.samratpharmachem.com/statutory-communications/ |
| 21 |
Disclosure of the policy for determination of materiality of events or information |
https://www.samratpharmachem.com/policy/materiality-of-events/ |
| 22 |
Disclosure of contact details of key managerial personnel who are authorized for the purpose of determining materiality of an event or information and for the purpose of making disclosures to stock exchange(s) |
https://www.samratpharmachem.com/share-transfer-agent/ |
| 23 |
All such events or information which has been disclosed to stock exchange(s) under regulation 30 of LODR |
https://www.samratpharmachem.com/statutory-communications/ |
| 24 |
Statements of deviation(s) or variation(s) |
– |
| 25 |
Dividend distribution policy by listed entities based on market capitalization |
https://www.samratpharmachem.com/policy/dividend-distribution-policy/ |
| 26 |
Annual return as provided under section 92 of the Companies Act, 2013 and the rules made thereunder |
https://www.samratpharmachem.com/annual-returns/ |
| 27 |
Name of the Debenture Trustees with full contact details |
– |
| 28 |
The Information, Report, Notices, Call letters, Circulars, Proceedings, etc. concerning non-convertible redeemable preference shares or non-convertible debt securities |
– |
| 29 |
All Information and Reports including Compliance Reports filed by the listed entity |
https://www.samratpharmachem.com/statutory-communications/ |
